A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis November 2, 2021 · by Aviatior · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. · https://www.docwirenews.com/condition-center/multiple-sclerosis-knowledge-hub/a-phase-ii-clinical-trial-with-repeated-intrathecal-injections-of-autologous-mesenchymal-stem-cells-in-patients-with-amyotrophic-lateral-sclerosis/ Share this:Share on TumblrTweetWhatsAppTelegramEmailPrintMorePocketLike this:Like Loading... Related